<code id='EBFD1F9BD0'></code><style id='EBFD1F9BD0'></style>
    • <acronym id='EBFD1F9BD0'></acronym>
      <center id='EBFD1F9BD0'><center id='EBFD1F9BD0'><tfoot id='EBFD1F9BD0'></tfoot></center><abbr id='EBFD1F9BD0'><dir id='EBFD1F9BD0'><tfoot id='EBFD1F9BD0'></tfoot><noframes id='EBFD1F9BD0'>

    • <optgroup id='EBFD1F9BD0'><strike id='EBFD1F9BD0'><sup id='EBFD1F9BD0'></sup></strike><code id='EBFD1F9BD0'></code></optgroup>
        1. <b id='EBFD1F9BD0'><label id='EBFD1F9BD0'><select id='EBFD1F9BD0'><dt id='EBFD1F9BD0'><span id='EBFD1F9BD0'></span></dt></select></label></b><u id='EBFD1F9BD0'></u>
          <i id='EBFD1F9BD0'><strike id='EBFD1F9BD0'><tt id='EBFD1F9BD0'><pre id='EBFD1F9BD0'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:3738
          Darron Cummings/AP

          Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

          The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

          advertisement

          Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          Inside the culture of fear in the White House science office of Eric Lander
          Inside the culture of fear in the White House science office of Eric Lander

          EricLanderresignedasPresidentBiden’sscienceadviser,afteraWhiteHouseinvestigationfound“credibleeviden

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

          AfreighttrainrunsonrailsofarailwaylinkoftheCrimeanBridgeconnectingRussianmainlandandCrimeanpeninsula